|

4um.com
Click Here to return to
the
Tutorial Index Page
|
|

Hypertension and Anaesthesia
By
Patrick Neligan, June 1998
All
tutorials located on this site are the property of Patrick
Neligan and are for personal study purposes only. They are not
peer reviewed and no responsibility is taken for inaccuracies. These
tutorials must not be reproduced without permission or used in any
other publication.
Contents
- Clinical scenarios*
- What is hypertension?
Classification of hypertension
- Why is hypertension important?
- Treatment of hypertension
- Pathophysiology of hypertension
[pheripheral blood vessels]
- End organ damage (resulting
from hypertension)
- Preoperative hypertension and
perioperative risk
- Methods of reducing
perioperative risk
- Acute Postoperative
Hypertension
- Hypertensive emergencies
- Key points
*Solutions to these
scenarios are not presented here at present. In reality there are no
black and white answers. What really matters is that you have a rational
and safe arguement for the decisions you take.
CLINICAL SCENARIOS
CASE 1
A 56 year old male presents for inguinal hernia repair. PMHx NAD. On
no medications. On examination his BP is 190/110, and his ECG shows LVH
with strain.
How would you manage this patient?
CASE 2
A 61 year old female undergoes an anterior resection for rectal
carcinoma. She has known hypertension, treated with Amlodipine 5mg
daily. In the recovery room postoperative, her blood pressure rises to
195/100.
How would you manage this patient?
CASE 3
A 79 year old female is admitted through A&E following a stroke.
She has fallen down the stairs and has a subcapsular fracture of her
right femur. On examination, she has a left hemiparesis. Her GCS score
is 12. Her blood pressure is 220/120. She has bilateral papilloedema.
The orthopaedic team are anxious to repair her hip to prevent fat
embolism.
How would you manage this patient?
CASE 4
A 64 year old female, who is awaiting CABG, undergoes right carotid
endarterectomy for a 90% occlusion. Her regular medications are
isosorbide mononitrate 60 mg daily, diltiazem 90 mg bd, aspirin 75 mg
daily and metoprolol 50 mg daily. You are called to see her in the high
dependency unit. Her blood pressure is 200/90; her heart rate is 88.
How would you manage this patient?
CASE 5
A 33 year old female undergoes a laparoscopic cholecystectomy. Apart
from her history of gallstones, her only other complaint is migraine.
She has no known allergies. Family history is non contributory. In the
anaesthetic room, her pulse was 110 and her BP was 110/60. Anaesthesia
was induced with fentanyl, propofol and vecuronium. She has had morphine
10mg and cyclizine 25mg, and is expiring 1.3% isoflurane in 70% nitrous
oxide.Twenty minutes after incision, her blood pressure suddenly rises
to 210/110, and her heart rate increases to 150 beats/min.
How would you manage this patient?
WHAT IS HYPERTENSION?
Joint National Committee on Detection, Evaluation and Treatment of
High Blood Pressure Arch Intern Med 153:154, 1993
|
Category |
Systolic (mmHg) |
Diastolic (mmHg) |
|
Normal |
<130 |
<85 |
|
High Normal |
130 - 139 |
85 - 89 |
|
Hypertension |
|
Stage 1 (mild) |
140 - 159 |
90 - 99 |
|
Stage 2 (moderate) |
160 - 179 |
100 - 109 |
|
Stage 3 (severe) |
180 - 209 |
110 - 119 |
|
Stage 4 (very severe) |
>210 |
>120 |
Diagnosis of hypertension (HTN) is made when two or more readings (on
different visits), of diastolic blood pressure (BP) >90 mmHg, or
systolic BP >140 mmHg.
Isolated systolic hypertension: SBP > 140 mmHg, DBP <90 mmHg.
Essential hypertension: no cause can be found (95% of cases).
Accelerated hypertension: markedly elevated HTN plus grade 3
retinopathy (haemorrhages and exudates).
Malignant hypertension: markedly elevated HTN (diastolic>140mmHg)
plus papilloedema.
Complicated hypertension: HTN plus cardiovascular ("end
organ") damage consequent to it: stroke, CCF, renal failure, MI,
AAA.
White coat hypertension: BP only raised when examined by a health
care professional.
CLASSIFICATION
Primary ["Essential"] hypertension.
Secondary hypertension:
A) Systolic hypertension with wide pulse
pressure:
- Aortic regurgitation
- Thyrotoxicosis
- Patent ductus arteriosus
B) Systolic and diastolic hypertension with increased PVR
1. Renal
- Glomerulonephritis (acute or chronic)
- Pyelonephritis
- Polycystic kidneys
- Renal artery stenosis
- Polycystic kidneys
2. Endocrine
- Cushing’s syndrome (excessive glucocorticoids)
- Congential adrenal hyperplasia
- Conn’s syndrome (primary hyperaldosteronism)
- Phaeochromocytoma
- Hypothyroidism
- Acromegaly
3. Neurogenic
- Raised intracranial pressure
- Psychological ("white coat hypertension")
- Acute porphyria
- Lead poisoning
4. Miscellaneous
- Coarctation of the aorta
- Polyarteritis Nodosa
- Hypercalcaemia
- Increased intravascular volume (PRV)
WHY IS
HYPERTENSION IMPORTANT?
- It is common (50 million Americans).
- It is a risk factor for cardiovascular disease.
- It causes end organ damage: heart, brain, kidneys
- It may indicate the presence serious endocrine related disese:
diabetes, thyrotoxicosis, phaeochromocytoma, Cushing’s, Conn’s,
etc.
- It may indicate the presence of serious renal disease.
- It increases the risk of an adverse anaesthetic outcome.
- Perioperatively it indicates:
Anxiety
Inadequate anaesthesia [awareness]
Inadequate analgesia.
TREATMENT OF
HYPERTENSION
Diuretics
Thiazide diuretics – reduce blood volume and vasodilate
Loop diuretics – much less effective
Sympathoplegics
1. Receptors: Beta blockers – reduce cardiac output initially,
later ¯ PVR
Alpha blockers – useful in diabetics or as second line tx
2. CNS active agents: Methyldopa and clonidine, a 2 selective,
decrease sympathetic outflow [mechanism unknown]. Salt retention.
Rebound HTN.
3. Ganglion blockers: block sympathetic ganglia. Cause postural
hypotension.
4. Post ganglionic sympathetic nerve terminal blockers. Drugs that
deplete nerve terminal of NAD stores (reserpine), block release of NAD (guanethidine).
Vasodilators
1. Nitroprusside – vasodilatation secondary to nitric oxide
activity.
2. Hydralazine – action unknown, acts on arterioles.
3. Calcium channel blockers – nifedipine, diltiazem, amlodopine.
4. Nitrates – vasodilation secondary to release of nitric oxide,
dilate veins>arteries>arterioles.
Angiotensin Antagonists
Angiotensin converting enzyme inhibitors antagonise the conversion of
Angiotensin I to Angiotensin II, and the metabolism of bradykinin.
Angiotensin is a vasoconstrictor, which stimulated the release of
aldosterone (conserves salt and water in the kidney). Bradykinin a
vasodilator.
Others
Magnesium acts as a calcium channel blocker, thus vasodilating.
TREATMENT PROTOCOLS
Non urgent: Beta blocker +/- thiazide, or calcium channel blocker
(asthmatics) or ACE inhibitor (diabetes / associated CCF).
Urgent: GTN, then nitroprusside or labetolol, then hydralazine.
"Bring the BP down gently"
PATHOPHYSIOLOGY
OF ESSENTIAL HYPERTENSION
PERIPHERAL BLOOD
VESSELS
The arterial and arteriolar walls are thickened.
There is a high ratio of wall thickness to internal diameter.
Vascular contraction leads to an abnormally large increase in blood
pressure
There is relative hypovolaemia (reduced intravascular volume).
Vascular relaxation leads to a greater than expected decrease in
blood pressure.
Additionally, vascular relaxation unmasks the relative hypovolaemic
state.
Rehydration following relaxation causes rebound hypertension when
the status quo returns
END ORGAN DYSFUNCTION
1. THE HEART
ECG shows left ventricular hypertrophy with strain
BP = CO X PR
PERIPHERAL RESISTANCE (PR): circulating blood volume, vascular tone
(smooth muscle and local vasoactive agents) sympathetic nervous system
activity, renin-angiotensin – aldosterone axis, antidiuretic hormone,
atrial natiuretic peptide.
CARDIAC OUTPUT
CO = HR X SV
HEART RATE: depends on baroreceptor activity, sympathetic nervous
system activity and vagal tone
STROKE VOLUME depends on Preload (LVEDV), Afterload (LV systolic wall
tension and peripheral resistance), and contractility (Starling curve).
WALL TENSION: Laplace’s Law:
Wall tension = transmural pressure X ventricular radius / 2 X wall
thickness
In order to cope with the increased afterload, the heart
hypertrophies [increasing the denominator above]. This leads to
increased myocardial O2 requirement, and endomyocardial fibrosis.
Cardiac dilatation eventually follows, and subsequent heart failure.
Hypertension causes:
- Acceleration of atheromatous disease.
- Myocardial ischaemia in the absence of coronary artery disease.
- Decreased myocardial compliance and an increase in the atrial
contribution to diastolic filling and cardiac output.
- Congestive cardiac failure / pulmonary oedema.
Fleisher and Barash: Anaesthesia and Analgesia 1992 74; 586 – 598
"The risk for perioperative myocardial ischaemia is increased in
hypertensive patients with left ventricular hypertrophy."
2. BRAIN
Chronic Hypertension causes a shift to the right in cerebral and
renal autoregulation
Decreases in cerebral blood flow and cerebral ischaemia occur at
higher blood pressures than in normotensive patients.
Long term therapy: autoregulation curve shifts leftward normal.
Strandgaard S: Circulation 1976 53:720-27
Autoregulation of cerebral blood flow in hypertensive patients.
Lower limit of autoregulation was:
113mmHg in severe hypertension 73 mmHg in normotensive patients
Lowest limit of blood pressure tolerated without symptoms was:
65 mmHg in severe HTN, 53 mmHg in treated HTN, 43mmHg in
normotensives
This return to the right occurs after 8 – 12 months, maybe longer.
Clinical Pearl
We cannot measure cerebral autoregulation, so a good rule of thumb
is:
- A 25% decrease in MAP reaches the lower limit of autoregulation.
- A 55% decrease in MAP reaches symptomatic brain hypoperfusion.
- Remember that these patients may also have cerebrovascular and
carotid arterial disease. "Watershed" ischaemia may occur
with even relative hypoperfusion.
- Treatment of hypertension significantly reduces the incidence of
stroke.
3. RENAL
Chronic hypertension affects renal autoregulation in the same way as
the brain.
The kidneys are "sitting ducks" in hypertension.
- End organ damage to the kidneys from HTN: glomerular sclerosis,
abnormal distribution of renal blood flow & decreased GFR.
"Prerenal" hypoperfusion due to a sudden and sustained
decrease in BP (during anaesthesia for major surgery) leads to
postoperative renal insufficiency.
PREOPERATIVE
HYPERTENSION AND PERIOPERATIVE RISK
Determinants of risk:
- Level of blood pressure.
- Duration of treatment.
- Degree of end organ damage.
- Type of surgery.
Level of hypertension:
From Wolfstal SD MCNM 1993, Prys-Roberts BJA 1974, Charlson SGO 1991
- Severe HTN increased risk
: BP lability, myocardial ischaemia,
MI, pulmonary oedema arrhythmias, renal failure and neurologic damage.
From Goldman and Caldera Anesthesiology 1979
- Patients with mild to moderate hypertension are not at
increased risk of major morbid events.
- Patients with any form of preoperative hypertension, treated or
untreated, have an increased risk of post op HTN.
- Prolonged increases or decreases in MAP by 20 mmHg or 20%
increased risk of postoperative complications.
The Bottom Line
Asymptomatic patients with mild to moderate HTN (DBP<110 mmHg)
are not at increased risk.
The presence of severe end-organ damage (LVH, CRF, CVA, CAD, LVF)
increases the risk significantly.
Elective surgery should be postponed in the case of DBP>110 mmHg
+ complications, DBP>120 mmHg without.
Isolated systolic HTN <200 mmHg should not defer surgery unless
for vascular surgery or craniotomies (increased risk).
Type of surgery associated with increased risk:
Aortic surgery, carotid endarterectomy, CABG, craniotomies (aneurysm
clipping), AVM, posterior fossa surgery. All at risk of postop HTN
(Goldman).
METHODS
TO REDUCE PERIOPERATIVE RISK
1. Adequate preoperative blood pressure control.
Continue all antihypertensives up to and including the day of surgery
(except diuretics).
Delay elective surgery if SBP>200 mmHg, or if DBP >120 mmHg,
until BP <190/110 mmHg, preferably lowered to 140/90 mmHg over
several weeks.
Acute control within hours of surgery is inadvisable.
2. Antihypertensive therapy
Use of agents to attenuate the haemodynamic responses to intubation,
incision and extubation:
- Opioids – Fentanyl, Alfentanyl.
- Antihypertensives – Esmolol, Labetalol, Atenolol, Metoprolol,
clonidine, enalapril (one dose preop).
- Lignocaine
3. Hydration
Volume load the hypertensive patient prior to induction.
This helps to minimise the peaks and valleys that characterise the
hypertensive patient.
4. Choice of agents
Consider using agents with minimal haemodynamic effects – fentanyl,
thiopentone rather than propofol, pethidine rather than morphine,
vecuronium or cis-atracurium rather than atracurium, sevoflurane
induction etc.
5. Analgesia
Opioid and non steroidal anti-inflammatory agents prevent the
hypertensive response to pain, intra- and post- operatively.
ACUTE
POSTOPERATIVE HYPERTENSION
Differential diagnosis
Pain
Emergence excitement
Hypercarbia
Intolerance of endotracheal tube
Full bladder
Hypervolaemia
Hypothermia
Withdrawl of chronic therapy
Risk associated:
- Loss of vascular anastomoses
- Intracranial bleeding
- Myocardial ischaemia [particularly when associated with
tachycardia]
Treatment
Depends on
- The clinical situation
- The aetiology
- The degree of hypertension
- Analgesia must be optimized
- Hypertension, where worrisome, should be treated with: GTN,
Labetolol, Esmolol, Nitroprusside, Hydralazine etc. Avoid sublingual
nifedipine.
Malignant Hypertension is defined as:
A syndrome characterised by hypertension
accompanied by an encephalopathy or nephropathy
Common Causes of Hypertensive Crises
- Antihypertensive drug withdrawal (e.g., clonidine)
- Autonomic hyperactivity
- Collagen-vascular diseases Drugs (e.g., cocaine, amphetamines)
- Glomerulonephritis (acute)
- Head trauma
- Neoplasias (e.g., pheochromocytoma)
- Preeclampsia & eclampsia
- Renovascular hypertension
Pathophysiology
- Abrupt increases in systemic vascular resistance likely related to
humoral vasoconstrictors.
- Endothelial injury
- Fibrinoid necrosis of the arterioles
- Deposition of platelets and fibrin
- Breakdown of the normal autoregulatory function.
- The resulting ischemia prompts further release of vasoactive
substances completing a vicious cycle
CLINICAL MANIFESTATIONS
The manifestations of hypertensive crises are those of end-organ
dysfunction:
- Hypertensive encephalopathy
- Acute aortic dissection
- Acute myocardial infarction
- Acute cerebral vascular accident
- Acute hypertensive renal injury
- Acute congestive heart failure
It is important to recognize that the absolute
level of BP may not be as important as the rate of increase.
Patients with longstanding hypertension may tolerate systolic BPs of 200
mm Hg or diastolic BPs of up to 150 mm Hg without developing
hypertensive encephalopathy, while children or pregnant women may
develop encephalopathy with diastolic BPs 100 mm Hg.
Hypertensive
encephalopathy:
Headache
Altered level of consciousness and confusion.
Acute CVA with intraventricular bleeding or ischemic infarction may
result in focal neurological abnormalities.
Fundoscopy: advanced retinopathy with arteriolar changes,
hemorrhages,exudates, papilloedema.
Cardiovascular manifestations:
Angina
LVF
Acute myocardial infarction.
Aortic dissection.
Propagation of the dissection is dependent not only on the elevation
of the blood pressure itself, but also on the velocity of left
ventricular ejection.
Renal Manifestations:
Renal failure with oliguria and/or hematuria.
Management
The key to is the prompt recognition and initiation of
treatment.
- What was the patient's blood pressure prior to presentation, does
the patient have any prior or current complaints, and what
medications, prescription and nonprescription, has the patient
taken?
- Palpation of pulses in all extremities is necessary.
- A fundoscopic examination is mandatory
- FBC, urea, creatinine, urinalysis, chest x-ray, electrocardiogram
(and head computed tomography are useful in patients with evidence
of shortness of breath, chest pain, or neurological changes,
respectively).
- These tests are performed simultaneously with the initiation of
antihypertensive therapy.
Sodium Nitroprusside
Sodium nitroprusside is a combined arterial and venous vasodilator
that decreases both the afterload and preload.
It is a very potent agent.
The onset of action of this drug is within seconds, with a duration
of action of one-to-two minutes and a plasma half-life of three to
four minutes.
Continuous BP measurement is recommended.If the infusion is stopped,
the BP begins to rise immediately and returns to the pre-treatment
level within one to ten minutes.
Sodium nitroprusside is metabolized into cyanogen, which is
converted into thiocyanate by the enzyme thiosulfate
sulfurtransferase.Therefore,
cyanide poisoning may occur with prolonged intravenous administration of
sodium nitroprusside. Consider this diagnosis in patients who develop
central nervous system depression, seizures, lactic acidosis and/or
cardiovascular instability.The toxicity of sodium nitroprusside usually
occurs after several days of infusion however, it may occur within the
first 24 hours with high dose administration.
Calcium Channel Blockers: Nifedipine
Nifedipine is not absorbed through the buccal mucosa, and the common
order for administration sublingually should be changed to bite and
swallow.
Nifedipine causes direct vasodilatation of arterioles reducing
peripheral vascular resistance promptly.
The onset of action begins within 15 minutes of oral administration
and peaks at 30 minutes.
The duration of action may be four to six hours.
Sudden reductions in BP accompanying administration of nifedipine
may precipitate ischemic events.
Nifedipine also produces reflex tachycardia, which in turn, in
patients with preexisting coronary artery disease may induce
myocardial ischemia.
Labetalol
Labetalol is a combined blocker of the alpha and beta adrenergic
receptors.
When given intravenously, labetalol produces a prompt and controlled
reduction in BP in patients with hypertensive crises.
The effects of this drug begin five minutes after administration,
and may last for at least four to six hours.
The rapid fall in BP results from a decrease in peripheral vascular
resistance and a slight fall in cardiac output.
One of the advantages of this drug is that it is also effective as
an oral antihypertensive agent and once the initial parenteral
treatment has been established, it can be followed with oral
administration.
Esmolol
Esmolol is a beta-adrenergic blocking agent that has an extremely
brief elimination half-life (<10 minutes). This agent is available
for intravenous use both as a bolus and as an infusion.
KEY POINTS IN
HYPERTENSION
Hypertension is conventionally considered a BP of
>160/90,isolated SystolicHTN is age +130
Hypertension causes cardiovascular, renal, and cerebrovascular
disease. Treatment significantly lowers the risk.
95% of cases are "Primary". Causes of secondary HTN are
renal, endocrine or neurogenic in origin.
Hypertension causes thickening of arterial walls, an increased wall
thickness to lumen size ratio and relative hypovolaemia.. Larygoscopy
causes a greater than expected increase in BP and induction unmasks
relative hypovolaemia: "roller coaster"
Hypertension causes LVH, CCF& myocardial ischaemia.
Renal and brain autoregulation is reset at a higher level, the lower
limit of autoregulation is a 25% decrease in MAP. A 55% decrease
causes symptomatic brain hypoperfusion.
Anaesthesia can therefore precipitate myocardial, cerebral and renal
ischaemia.
Perioperative risk depends on the level of BP, duration of
treatment, degree of end organ damage, type of surgery.
Vascular and neurosurgery are associated with higher risk.
Elective surgery should be delayed in patients presenting with DBP>110
with end organ damage, DBP>120 without.
Prolonged increases or decreases in MAP by 20mmHg increases the risk
of perioperative complications.
Preoperative risk is minimised by continuing pre op medications, pre
induction hydration and the use of analgesics and other agents to
reduce the haemodynamic responses to intubation, surgery and
extubation.
Post op hypertension is assessed depending on the degree of HTN, the
clinical scenario and the aetiology of the HTN.
Hypertensive emergencies include encephalopathy, stroke, dissecting
aneurysm and phaeochromocytoma. Treatment is most effective with
nitrates, nitroprusside, beta blockers and hydralazine. Invasive
monitoring is essential.
Top of Page
4um.com
|
Copyright 1999
4um.com, owned and operated by Pat Neligan
|
|
|
|